CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Praxis Precision Medicines, Inc. - PRAX CFD

38.91
2.63%
  • Summary
  • Historical Data
Trading сonditions
Spread 0.25
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.026207 %
Charges from full value of position ($-4.98)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026207%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.003985 %
Charges from full value of position ($0.76)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003985%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 39.96
Open 39.7
1-Year Change 4311.11%
Day's Range 38.75 - 40.48
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jun 14, 2024 38.91 -0.64 -1.62% 39.55 40.67 38.57
Jun 13, 2024 39.96 -0.26 -0.65% 40.22 42.14 39.25
Jun 12, 2024 40.89 1.56 3.97% 39.33 41.23 38.67
Jun 11, 2024 39.36 -1.11 -2.74% 40.47 40.47 38.93
Jun 10, 2024 40.42 0.46 1.15% 39.96 40.68 39.10
Jun 7, 2024 40.42 -2.53 -5.89% 42.95 42.95 40.16
Jun 6, 2024 43.60 -0.38 -0.86% 43.98 43.98 40.72
Jun 5, 2024 44.10 -1.01 -2.24% 45.11 46.85 43.95
Jun 4, 2024 45.75 -1.15 -2.45% 46.90 47.27 45.32
Jun 3, 2024 46.79 0.36 0.78% 46.43 47.68 45.15
May 31, 2024 47.40 2.06 4.54% 45.34 47.47 45.34
May 30, 2024 45.42 -0.51 -1.11% 45.93 47.28 44.91
May 29, 2024 46.07 2.07 4.70% 44.00 46.41 43.39
May 28, 2024 45.15 1.20 2.73% 43.95 45.51 43.82
May 24, 2024 43.88 1.97 4.70% 41.91 43.88 40.96
May 23, 2024 42.66 0.18 0.42% 42.48 43.39 39.52
May 22, 2024 42.48 -2.27 -5.07% 44.75 45.25 42.15
May 21, 2024 44.72 -0.23 -0.51% 44.95 47.45 43.73
May 20, 2024 44.76 -0.08 -0.18% 44.84 45.09 44.00
May 17, 2024 45.08 1.05 2.38% 44.03 46.61 43.68

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Praxis Precision Medicines, Inc. Company profile

About Praxis Precision Medicines Inc

Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal imbalance. Its development stage products include PRAX-114, PRAX-944 and PRAX-562. PRAX-114 is an extrasynaptic-preferring gamma-aminobutyric acid-A (GABAA) receptor positive allosteric modulator (PAM) for the treatment of patients suffering from major depressive disorder (MDD) and perimenopausal depression (PMD). PRAX-944 is a differentiated selective small molecule inhibitor of T-type calcium channel, for the treatment of essential tremor (ET). PRAX-562 is the selective, persistent sodium current blocker in development for the treatment of a range of CNS disorders.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Praxis Precision Medicines Inc revenues was not reported. Net loss applicable to common stockholders increased from $70.3M to $167.1M. Higher net loss reflects Stock based compensation increase from $43.6M to $89.2M (expense), General and administrative increase from $13.1M to $33.7M (expense), Stock-based Compensation in SGA increase from $3.9M to $13.3M (expense).

Industry: Biotechnology & Medical Research (NEC)

99 High Street, 30th Floor
BOSTON
MASSACHUSETTS 02110
US

News

Bank of Japan Preview: Markets look for guidance from BOJ about timing of next hike

The Bank of Japan meets on Friday, 14th of June, 2024. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

11:05, 12 June 2024

FOMC preview: Still expecting three rate cuts in 2024?

The Federal Reserve is expected to keep its policy unchanged on Wednesday – data from Reuters shows a 99% chance of no change. Last week’s 25-basis-point rate cut from the ECB has done nothing to change market expectations, and why should it?

08:20, 11 June 2024

US Non-Farm Payrolls Preview: Forecasts point to a stable labour market

US labour market conditions are expected to have remained stable in May. The latest Non-Farm Payrolls data will be released on Friday, June 7th, 2024, and will provide a health check on the US jobs market.

10:09, 5 June 2024

AUD/USD analysis: Focus turns to GDP data after unexpected CPI rise

Higher-than-expected monthly CPI data watered down expectations for RBA interest rate cuts in 2024; the markets will now shift attention to quarterly GDP data on Wednesday, June 5.

15:57, 4 June 2024

ECB preview: A cut, but how many more?

After months of waiting, a rate cut from the ECB on Thursday looks like a done deal. Data from Reuters shows markets pricing in a 96% chance of a 25-basis point cut from the European Central Bank following Thursday’s policy meeting.

08:54, 4 June 2024

PCE Index Preview: Forecasts point to no change in headline or core inflation from a month earlier

The markets continue to look for signals of disinflation in the United States. The latest PCE Index data, the US Federal Reserve’s preferred inflation gauge, is released on May 31, 2024.

12:44, 29 May 2024

Gold and Silver recover from last week’s pullback but face resistance ahead of US PCE

Gold and Silver move higher after last week’s pullbacks but the precious metals are struggling with resistance ahead of the US PCE release.

15:46, 28 May 2024

People also watch

ETH/USD

3,625.10 Price
+1.920% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

XRP/USD

0.49 Price
-0.600% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

BTC/USD

66,680.05 Price
+0.880% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

Gold

2,328.22 Price
-0.270% 1D Chg, %
Long position overnight fee -0.0190%
Short position overnight fee 0.0107%
Overnight fee time 21:00 (UTC)
Spread 0.40

Still looking for a broker you can trust?

Join the 620,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading